Impact of flow and angioarchitecture on brain arteriovenous malformation outcome after gamma knife radiosurgery: the role of hemodynamics and morphology in obliteration.


Journal

Acta neurochirurgica
ISSN: 0942-0940
Titre abrégé: Acta Neurochir (Wien)
Pays: Austria
ID NLM: 0151000

Informations de publication

Date de publication:
07 2020
Historique:
received: 15 11 2019
accepted: 14 04 2020
pubmed: 27 4 2020
medline: 6 1 2021
entrez: 27 4 2020
Statut: ppublish

Résumé

Few studies have evaluated the relationship between brain arteriovenous malformations (bAVMs) angioarchitecture and the response to Gamma Knife Stereotactic Radiosurgery (GKSR). A prospectively enrolled single-center cohort of patients with bAVMs treated by GKSR has been studied to define independent predictors of obliteration with particular attention to angioarchitectural variables. Only patients older than 18 years old (y.o.), who underwent baseline digital subtraction angiography (DSA) and clinico-radiological follow-up of at least 36 months, were included in the study. Data of 191 patients were evaluated. After a mean follow-up of 80 months (range 37-173), total obliteration rate after first GKSR treatment was 66%. Mean dose higher than 22 Gy (P = .019, OR = 2.39, 95% CI 1.15-4.97) and flow rate dichotomized into high vs non-high (P < .001, OR = 0.23, 95% CI 0.11-0.51) resulted to be independent predictors of obliteration. Flow-surrogate angioarchitectural features did not emerge as independent outcome predictors. Flow rate seems to be associated in predicting outcome after GKSR conferring high-flow AVM a lower occlusion rate. Its role should be considered when planning radiosurgical treatment of bAVM, and it could be added to other parameters used in GKRS outcome predicting scales.

Sections du résumé

BACKGROUND
Few studies have evaluated the relationship between brain arteriovenous malformations (bAVMs) angioarchitecture and the response to Gamma Knife Stereotactic Radiosurgery (GKSR).
METHODS
A prospectively enrolled single-center cohort of patients with bAVMs treated by GKSR has been studied to define independent predictors of obliteration with particular attention to angioarchitectural variables. Only patients older than 18 years old (y.o.), who underwent baseline digital subtraction angiography (DSA) and clinico-radiological follow-up of at least 36 months, were included in the study.
RESULTS
Data of 191 patients were evaluated. After a mean follow-up of 80 months (range 37-173), total obliteration rate after first GKSR treatment was 66%. Mean dose higher than 22 Gy (P = .019, OR = 2.39, 95% CI 1.15-4.97) and flow rate dichotomized into high vs non-high (P < .001, OR = 0.23, 95% CI 0.11-0.51) resulted to be independent predictors of obliteration. Flow-surrogate angioarchitectural features did not emerge as independent outcome predictors.
CONCLUSIONS
Flow rate seems to be associated in predicting outcome after GKSR conferring high-flow AVM a lower occlusion rate. Its role should be considered when planning radiosurgical treatment of bAVM, and it could be added to other parameters used in GKRS outcome predicting scales.

Identifiants

pubmed: 32335814
doi: 10.1007/s00701-020-04351-4
pii: 10.1007/s00701-020-04351-4
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1749-1757

Auteurs

Pietro Panni (P)

Department of Neurosurgery and Gamma Knife Radiosurgery, San Raffaele Scientific Institute, Vita-Salute University, Via Olgettina 60, 20132, Milan, Italy. panni.pietro@hsr.it.
Department of Neuroradiology, Interventional Neuroradiology Unit, San Raffaele Scientific Institute, Vita-Salute University, Milan, Italy. panni.pietro@hsr.it.

Alberto Luigi Gallotti (AL)

Department of Neurosurgery and Gamma Knife Radiosurgery, San Raffaele Scientific Institute, Vita-Salute University, Via Olgettina 60, 20132, Milan, Italy.

Carmen Rosaria Gigliotti (CR)

Department of Medical Physics, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Ahmed Badry Shehata (AB)

Department of Neurosurgery and Gamma Knife Radiosurgery, San Raffaele Scientific Institute, Vita-Salute University, Via Olgettina 60, 20132, Milan, Italy.
Department of Neuroradiology, Interventional Neuroradiology Unit, San Raffaele Scientific Institute, Vita-Salute University, Milan, Italy.
Department of Medical Physics, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Department of Neurosurgery, Suez Canal University, Ismailia, Egypt.

Luigi Albano (L)

Department of Neurosurgery and Gamma Knife Radiosurgery, San Raffaele Scientific Institute, Vita-Salute University, Via Olgettina 60, 20132, Milan, Italy.

Camillo Ferrari da Passano (CF)

Department of Neurosurgery and Gamma Knife Radiosurgery, San Raffaele Scientific Institute, Vita-Salute University, Via Olgettina 60, 20132, Milan, Italy.

Raffaella Lina Alessandra Barzaghi (RLA)

Department of Neurosurgery and Gamma Knife Radiosurgery, San Raffaele Scientific Institute, Vita-Salute University, Via Olgettina 60, 20132, Milan, Italy.

Jody Filippo Capitanio (JF)

Department of Neurosurgery and Gamma Knife Radiosurgery, San Raffaele Scientific Institute, Vita-Salute University, Via Olgettina 60, 20132, Milan, Italy.

Claudio Righi (C)

Department of Neuroradiology, Interventional Neuroradiology Unit, San Raffaele Scientific Institute, Vita-Salute University, Milan, Italy.

Franco Simionato (F)

Department of Neuroradiology, Interventional Neuroradiology Unit, San Raffaele Scientific Institute, Vita-Salute University, Milan, Italy.

Francesco Scomazzoni (F)

Department of Neuroradiology, Interventional Neuroradiology Unit, San Raffaele Scientific Institute, Vita-Salute University, Milan, Italy.

Antonella Del Vecchio (A)

Department of Medical Physics, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Andrea Falini (A)

Department of Neuroradiology, Interventional Neuroradiology Unit, San Raffaele Scientific Institute, Vita-Salute University, Milan, Italy.

Pietro Mortini (P)

Department of Neurosurgery and Gamma Knife Radiosurgery, San Raffaele Scientific Institute, Vita-Salute University, Via Olgettina 60, 20132, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH